GDRX logo

GoodRx Holdings, Inc. (GDRX) Depreciation & Amortization

Annual D&A:

$69.54M-$42.23M(-37.79%)
December 31, 2024

Summary

  • As of today, GDRX annual D&A is $69.54 million, with the most recent change of -$42.23 million (-37.79%) on December 31, 2024.
  • During the last 3 years, GDRX annual D&A has risen by +$31.90 million (+84.74%).
  • GDRX annual D&A is now -37.79% below its all-time high of $111.77 million, reached on December 31, 2023.

Performance

GDRX Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

Quarterly D&A:

$21.43M+$1.70M(+8.63%)
September 30, 2025

Summary

  • As of today, GDRX quarterly D&A is $21.43 million, with the most recent change of +$1.70 million (+8.63%) on September 30, 2025.
  • Over the past year, GDRX quarterly D&A has increased by +$3.90 million (+22.22%).
  • GDRX quarterly D&A is now -55.08% below its all-time high of $47.71 million, reached on December 31, 2023.

Performance

GDRX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

TTM D&A:

$81.17M+$3.90M(+5.04%)
September 30, 2025

Summary

  • As of today, GDRX TTM D&A is $81.17 million, with the most recent change of +$3.90 million (+5.04%) on September 30, 2025.
  • Over the past year, GDRX TTM D&A has dropped by -$16.99 million (-17.31%).
  • GDRX TTM D&A is now -27.38% below its all-time high of $111.77 million, reached on December 31, 2023.

Performance

GDRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

GDRX Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-37.8%+22.2%-17.3%
3Y3 Years+84.7%+45.2%+55.3%
5Y5 Years+342.3%+237.0%+433.1%

GDRX Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-37.8%+84.7%-55.1%+45.2%-27.4%+55.3%
5Y5-Year-37.8%+342.3%-55.1%+293.2%-27.4%+433.1%
All-TimeAll-Time-37.8%+609.1%-55.1%+393.2%-27.4%+1768.1%

GDRX Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$21.43M(+8.6%)
$81.17M(+5.0%)
Jun 2025
-
$19.73M(-5.7%)
$77.27M(+3.7%)
Mar 2025
-
$20.91M(+9.5%)
$74.51M(+7.1%)
Dec 2024
$69.54M(-37.8%)
$19.10M(+8.9%)
$69.54M(-29.2%)
Sep 2024
-
$17.54M(+3.4%)
$98.15M(-12.0%)
Jun 2024
-
$16.96M(+6.4%)
$111.59M(-0.1%)
Mar 2024
-
$15.94M(-66.6%)
$111.73M(-0.0%)
Dec 2023
$111.77M(+94.3%)
$47.71M(+54.1%)
$111.77M(+38.6%)
Sep 2023
-
$30.97M(+81.0%)
$80.63M(+25.2%)
Jun 2023
-
$17.11M(+7.1%)
$64.42M(+4.9%)
Mar 2023
-
$15.98M(-3.5%)
$61.41M(+6.7%)
Dec 2022
$57.53M
$16.57M(+12.3%)
$57.53M(+10.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
$14.76M(+4.7%)
$52.26M(+8.1%)
Jun 2022
-
$14.10M(+16.5%)
$48.32M(+11.1%)
Mar 2022
-
$12.10M(+7.1%)
$43.51M(+15.6%)
Dec 2021
$37.64M(+64.3%)
$11.30M(+4.4%)
$37.64M(+18.4%)
Sep 2021
-
$10.82M(+16.5%)
$31.79M(+16.3%)
Jun 2021
-
$9.29M(+49.0%)
$27.33M(+21.1%)
Mar 2021
-
$6.23M(+14.3%)
$22.56M(+9.1%)
Dec 2020
$22.91M(+45.7%)
$5.45M(-14.3%)
$20.68M(+35.8%)
Sep 2020
-
$6.36M(+40.7%)
$15.22M(+71.7%)
Jun 2020
-
$4.52M(+4.1%)
$8.87M(+104.1%)
Mar 2020
-
$4.34M
$4.34M
Dec 2019
$15.72M(+60.3%)
-
-
Dec 2018
$9.81M
-
-

FAQ

  • What is GoodRx Holdings, Inc. annual D&A?
  • What is the all-time high annual D&A for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. annual D&A year-on-year change?
  • What is GoodRx Holdings, Inc. quarterly D&A?
  • What is the all-time high quarterly D&A for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?
  • What is GoodRx Holdings, Inc. TTM D&A?
  • What is the all-time high TTM D&A for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. TTM D&A year-on-year change?

What is GoodRx Holdings, Inc. annual D&A?

The current annual D&A of GDRX is $69.54M

What is the all-time high annual D&A for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high annual D&A is $111.77M

What is GoodRx Holdings, Inc. annual D&A year-on-year change?

Over the past year, GDRX annual D&A has changed by -$42.23M (-37.79%)

What is GoodRx Holdings, Inc. quarterly D&A?

The current quarterly D&A of GDRX is $21.43M

What is the all-time high quarterly D&A for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high quarterly D&A is $47.71M

What is GoodRx Holdings, Inc. quarterly D&A year-on-year change?

Over the past year, GDRX quarterly D&A has changed by +$3.90M (+22.22%)

What is GoodRx Holdings, Inc. TTM D&A?

The current TTM D&A of GDRX is $81.17M

What is the all-time high TTM D&A for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high TTM D&A is $111.77M

What is GoodRx Holdings, Inc. TTM D&A year-on-year change?

Over the past year, GDRX TTM D&A has changed by -$16.99M (-17.31%)
On this page